HomeMarkets Markets CRISPR, Genetics And AI — Why 2023 Could Be Biotech’s Year By news February 4, 2023 0 75 FacebookTwitterPinterestWhatsApp If there’s one overarching theme that investors in biotech stocks should pay attention to in 2023, it’s “genetic medicine, genetic medicine, genetic …This post was originally published on this site Share FacebookTwitterPinterestWhatsApp Subscribe Login Notify of new follow-up comments new replies to my comments Please login to comment 0 Comments Inline Feedbacks View all comments Stay Connected157,450FansLike396,312FollowersFollow2,280SubscribersSubscribe Latest Articles Charts Reddit’s IPO, DJT Surge, Micron’s AI Game Plan, Untapped Opportunities, and More Markets Kind of Quad Witching Thursday Hot Items More Than Hon Hon Hon: What Are the French Up to in Ukraine? Earth, Climate Chevron Will Pay Record Fines for Oil Spills in California Hot Items Baltimore bridge collapse: a bridge engineer explains what happened, and what needs to change Load more